Recalls annual report 2019-20

The Recalls Annual Report provides an understanding of our regulatory activities, stakeholder engagement and improvements made to our regulatory requirements to meet our objectives achievements required to meet our objectives under the TGA's Business Plan for 2019-20, in regard to the removal of products from the market that pose an unacceptable risk to consumers.

During the 2019-20 financial year, the TGA:

• Coordinated 790 recalls for medicines, medical devices, blood products and biological products.

A high number of recalls were due to labelling and packaging and impurity and degradation issues.